Identified a panel of differentially expressed circRNAs in DS maternal–fetal circulation; proposed that certain circRNAs (e.g., derived from USP25 and RUNX1) could serve as potential non-invasive biomarkers for DS detection. This evidence concerns the gene USP25 and Dravet syndrome.